Raymond James & Associates Tandem Diabetes Care Inc Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Raymond James & Associates holds 96,671 shares of TNDM stock, worth $4.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,671

Previous 96,848 0.18%

Holding current value

$4.25 Million

Previous $3.43 Million 13.56%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$30.43 - $53.43 $5,386 - $9,457	-177 Reduced 0.18%	96,671 $3.89 Million
Q1 2024 Apr 22, 2024	BUY	$22.09 - $35.41 $107,423 - $172,198	4,863 Added 5.29%	96,848 $3.43 Million
Q4 2023 Jan 16, 2024	BUY	$14.28 - $31.03 $738,575 - $1.6 Million	51,721 Added 128.45%	91,985 $2.72 Million
Q3 2023 Oct 24, 2023	BUY	$19.33 - $36.22 $14,246 - $26,694	737 Added 1.86%	40,264 $836,000
Q2 2023 Jul 25, 2023	BUY	$24.18 - $42.46 $80,712 - $141,731	3,338 Added 9.22%	39,527 $969,000
Q1 2023 Apr 14, 2023	BUY	$35.86 - $46.5 $187,762 - $243,474	5,236 Added 16.92%	36,189 $1.47 Million
Q4 2022 Feb 08, 2023	BUY	$35.49 - $56.15 $278,241 - $440,216	7,840 Added 33.92%	30,953 $1.39 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $68.97 $215,955 - $340,366	4,935 Added 27.15%	23,113 $1.11 Million
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $100,000 - $231,286	1,879 Added 11.53%	18,178 $1.08 Million
Q1 2022 May 11, 2022	SELL	$101.89 - $150.09 $549,492 - $809,435	-5,393 Reduced 24.86%	16,299 $1.9 Million
Q4 2021 Feb 08, 2022	BUY	$118.18 - $153.21 $484,183 - $627,701	4,097 Added 23.29%	21,692 $3.27 Million
Q3 2021 Nov 02, 2021	SELL	$93.51 - $129.4 $107,723 - $149,068	-1,152 Reduced 6.14%	17,595 $2.1 Million
Q2 2021 Aug 11, 2021	BUY	$77.0 - $100.19 $105,182 - $136,859	1,366 Added 7.86%	18,747 $1.83 Million
Q1 2021 May 14, 2021	SELL	$81.28 - $104.34 $442,732 - $568,339	-5,447 Reduced 23.86%	17,381 $1.53 Million
Q4 2020 Feb 12, 2021	SELL	$86.4 - $121.75 $3.43 Million - $4.83 Million	-39,710 Reduced 63.5%	22,828 $2.18 Million
Q3 2020 Nov 04, 2020	BUY	$95.43 - $116.09 $1.67 Million - $2.03 Million	17,515 Added 38.9%	62,538 $7.1 Million
Q2 2020 Jul 28, 2020	BUY	$60.05 - $98.92 $216,720 - $357,002	3,609 Added 8.71%	45,023 $4.45 Million
Q1 2020 Apr 21, 2020	SELL	$47.37 - $90.04 $10,516 - $19,988	-222 Reduced 0.53%	41,414 $2.67 Million
Q4 2019 Feb 12, 2020	SELL	$53.13 - $71.19 $3.72 Million - $4.98 Million	-69,987 Reduced 62.7%	41,636 $2.48 Million
Q3 2019 Nov 07, 2019	BUY	$57.11 - $73.3 $137,577 - $176,579	2,409 Added 2.21%	111,623 $6.58 Million
Q2 2019 Aug 06, 2019	BUY	$54.41 - $71.7 $4.82 Million - $6.35 Million	88,532 Added 428.06%	109,214 $7.05 Million
Q1 2019 May 06, 2019	BUY	$32.25 - $73.56 $116,261 - $265,183	3,605 Added 21.11%	20,682 $1.31 Million
Q4 2018 Feb 11, 2019	BUY	$28.45 - $40.65 $286,633 - $409,548	10,075 Added 143.89%	17,077 $648,000
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $149,772 - $358,292	7,002 New	7,002 $300,000

Others Institutions Holding TNDM

# of Institutions

344

Shares Held

72.7M

Call Options Held

3.12M

Put Options Held

343K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.82B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Tandem Diabetes Care Inc Transaction History